(0.08%) 5 104.05 points
(0.17%) 38 303 points
(0.11%) 15 946 points
(-1.47%) $82.62
(5.77%) $2.03
(0.30%) $2 354.30
(-0.27%) $27.46
(3.87%) $957.80
(-0.18%) $0.933
(-0.32%) $10.99
(-0.50%) $0.796
(1.70%) $93.44
Quarter results tomorrow
(bmo 2024-04-30)
Expected move: +/- 4.25%
-0.43% INR 1 560.55
Live Chart Being Loaded With Signals
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally...
Stats | |
---|---|
Dagens volum | 10 391.00 |
Gjennomsnittsvolum | 20 441.00 |
Markedsverdi | 25.81B |
EPS | INR0 ( 2024-04-26 ) |
Neste inntjeningsdato | ( INR0 ) 2024-04-30 |
Last Dividend | INR12.00 ( 2023-07-21 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 30.45 |
ATR14 | INR2.16 (0.14%) |
Volum Korrelasjon
RPG Life Sciences Limited Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
RPG Life Sciences Limited Korrelasjon - Valuta/Råvare
RPG Life Sciences Limited Økonomi
Annual | 2022 |
Omsetning: | INR5.13B |
Bruttogevinst: | INR3.42B (66.68 %) |
EPS: | INR40.90 |
FY | 2022 |
Omsetning: | INR5.13B |
Bruttogevinst: | INR3.42B (66.68 %) |
EPS: | INR40.90 |
FY | 2022 |
Omsetning: | INR4.37B |
Bruttogevinst: | INR2.87B (65.64 %) |
EPS: | INR31.13 |
FY | 2021 |
Omsetning: | INR3.83B |
Bruttogevinst: | INR2.46B (64.10 %) |
EPS: | INR24.19 |
Financial Reports:
No articles found.
RPG Life Sciences Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR9.60 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR12.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR1.200 | 2008-08-11 |
Last Dividend | INR12.00 | 2023-07-21 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 16 | -- |
Total Paid Out | INR51.04 | -- |
Avg. Dividend % Per Year | 1.03% | -- |
Score | 2.26 | -- |
Div. Sustainability Score | 3.08 | |
Div.Growth Potential Score | 4.87 | |
Div. Directional Score | 3.97 | -- |
Year | Amount | Yield |
---|---|---|
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR2.40 | 0.61% |
2019 | INR2.40 | 1.01% |
2020 | INR4.00 | 1.26% |
2021 | INR7.20 | 1.92% |
2022 | INR9.60 | 1.57% |
2023 | INR12.00 | 1.41% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TIMETECHNO.NS | Dividend Junior | 2023-09-18 | Annually | 17 | 0.93% | |
PARADEEP.NS | No Dividend Player | 2023-09-18 | Insufficient data to determine frequency | 2 | 0.28% | |
IVC.NS | Dividend Knight | 2023-08-17 | Annually | 23 | 5.55% | |
DALBHARAT.NS | Dividend Junior | 2023-06-23 | Annually | 7 | 0.30% | |
SHRIPISTON.NS | Dividend Junior | 2023-06-27 | Semi-Annually | 9 | 0.89% | |
MATRIMONY.NS | Dividend Junior | 2023-08-03 | Annually | 7 | 0.41% | |
GRWRHITECH.NS | Dividend Junior | 2023-09-20 | Semi-Annually | 3 | 0.88% | |
BANDHANBNK.NS | Dividend Junior | 2023-08-11 | Sporadic | 7 | 0.20% | |
PPAP.NS | Ex Dividend Junior | 2023-09-08 | Annually | 17 | 0.34% | |
JWL.NS | Dividend Junior | 2023-09-12 | Insufficient data to determine frequency | 2 | 0.17% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.148 | 1.500 | 7.04 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.264 | 1.500 | 8.18 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 309.81 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 19.92 | 2.00 | 3.36 | 6.72 | [0 - 30] |
freeCashFlowPerShareTTM | 19.92 | 2.00 | 0.0418 | 0.0835 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.617 | 1.000 | 3.05 | 3.05 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.194 | 1.000 | 8.11 | 8.11 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.08 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 30.61 | 1.000 | 7.01 | 0 | [1 - 100] |
returnOnEquityTTM | 0.264 | 2.50 | 8.83 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 19.92 | 2.00 | 3.36 | 0.0835 | [0 - 30] |
dividendYielPercentageTTM | 0.765 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 19.92 | 2.00 | 3.36 | 6.72 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.067 | 1.500 | 6.22 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0574 | 1.000 | -1.064 | 0 | [0.1 - 0.5] |
Total Score | 4.87 |
RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular, diabetology, orthopedics, neuropsychiatry, respiratory, nutritional, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology and pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.